BRIDGE4BIO INC
Bridge4Bio is comprised of a global team of experts in leading and managing operations, marketing, sales and business development.
BRIDGE4BIO INC
Industry:
Advertising Business Development Marketing Sales
Founded:
2000-01-01
Address:
Causeway Bay, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.bridge4bio.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Google Analytics Apache Google Analytics Classic CPanel SSL
Similar Organizations
ParuPi
ParuPi Co., Ltd. is Community-based advertising in Yamanashi Prefecture's information magazines and media advertisements.
Official Site Inspections
http://www.bridge4bio.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bridge4Bio Inc"
BridgeBio | Biotechnology Company | Designing Transformative โฆ
BridgeBio is committed to developing leaders as well as drugs. We seek individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged โฆSee details»
BridgeBio | For Investors
BridgeBio Pharma Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from โฆSee details»
BridgeBio - Crunchbase Company Profile & Funding
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. โฆSee details»
BridgeBio - LinkedIn
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance ...See details»
BridgeBio | BridgeBio Announces Commercial Progress, Program โฆ
Jan 13, 2025 BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help โฆSee details»
Bridge4Bio Inc - Crunchbase Company Profile & Funding
Organization. Bridge4Bio Inc . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... GlobeNewswire News Room โ BridgeBio Initiates Long Term โฆSee details»
BridgeBio Pharma, Inc. - AnnualReports.com
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and โฆSee details»
BridgeBio - Contacts, Employees, Board Members, Advisors
Organization. BridgeBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... BridgeBio has 3 board members and โฆSee details»
BridgeBio Pharma
4 days ago BridgeBio was founded in 2015 by Neil Kumar and Nishanth Allegatu. The company initially focused on genetic disease research and has spun out more than 20 companies in the โฆSee details»
BridgeBio | BridgeBio Pharma, Inc. and Oregon Health & Science ...
Apr 13, 2021 BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help โฆSee details»
BridgeBio Announces Commercial Progress, Program Updates, โฆ
Jan 13, 2025 BridgeBio Pharma, Inc. ... we marked an important moment for both our organization and the broader ATTR-CM patient community in need of new treatment options. โฆSee details»
Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershberg
Feb 16, 2025 BridgeBioโs share price jumped back to over $30. In November of 2024, after a tumultuous journey, the company gained approval for acoramidis (now marketed as Attruby), โฆSee details»
BridgeBio - Overview, News & Similar companies | ZoomInfo.com
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PALO ALTO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) โฆSee details»
BridgeBio - VentureRadar
" BridgeBio Pharma is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their โฆSee details»
BridgeBio | BridgeBio Receives FDAโs Regenerative Medicine โฆ
Sep 10, 2024 - BridgeBio will leverage the benefits of RMAT designation, including early and more frequent interactions with the FDA, to establish an Accelerated Approval pathway for โฆSee details»
BridgeBio Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 BridgeBio has 2 employees at their 1 location and $221.9 m in annual revenue in FY 2024. See insights on BridgeBio including office locations, competitors, revenue, financials, โฆSee details»
Hello BridgeBio, farewell Syros and Achilles | ApexOnco - Clinical ...
Mar 3, 2025 BridgeBio Oncology is the cancer-focused unit of Bridge Bio, formally spun out last year with a focus on KRAS inhibition (BBO-11818 and BBO-8520) and the PI3Kฮฑ:RAS breaker โฆSee details»
First Participant Dosed with Acoramidis in ACT-EARLY, the First โฆ
3 hours ago BridgeBio Pharma (NASDAQ: BBIO) has initiated ACT-EARLY, the first-ever primary prevention study for ATTR amyloidosis, with the first participant receiving acoramidis. โฆSee details»
BridgeBio | BridgeBio Pharma and Brown University Announce โฆ
Apr 13, 2021 BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help โฆSee details»
First Participant Dosed with Acoramidis in ACT-EARLY, the First โฆ
3 hours ago About Pharma, Inc. BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test and deliver transformative โฆSee details»